The activation of SMAD3 in TGF-β signaling leads to the upregulation of extracellular matrix proteins, contributing significantly to the muscle stiffness and fibrosis seen in DMD patients (Bernasconi et al., 1999; Qin et al., 2011). The gene discussed is SMAD3; the disease is Duchenne muscular dystrophy.